ProBioGen and Marea Therapeutics Inc. have successfully completed a sprint project to deliver clinical material for MAR002.

NAPS Global India IPO has received a muted response from investors so far, with the subscription reaching nearly 42 per cent ...

The NAPS Global India IPO launched on March 5, priced at ₹90 per share, with a minimum bid of 1,600 shares. The company, a ...

ABVC BioPharma Plans to Expand Investment in U.S. for Production Facilities and Products for Unmet Medical Needs 05.03.2025 / 22:07 CET/CEST The issuer is solely responsible for the content of this ...

Over $100 Million Invested in the U.S. FREMONT, CA - March 5, 2025 (NEWMEDIAWIRE) - ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical-stage biopharmaceutical company focused on innovative treatments in ...

Scinai Immunotherapeutics (NASDAQ: SCNI) , a biopharmaceutical company focused on inflammation and immunology biological products and contract develo ...

One of the pioneers of CAR T-cell therapy, Dr. Brentjens spoke with Becker's about what the new facility means for cancer innovation, as well as on how leaders across the U.S. can best integrate CAR T ...

Balaji Phosphates IPO allotment will be finalised today, March 5. Investors can check their allotment status on Skyline ...

Begin with Quality Ingredients Cell culture media are essential for providing the nutrients, vitamins, and minerals necessary ...

The National Agency for Food and Drug Administration and Control (NAFDAC) on Tuesday cracked down on illegal sachet water production in Dutse Alhaji and Dawaki, Federal Capital Territory (FCT).

Shreenath Paper share price made a weak debut on NSE SME, opening at ₹35.20, 20% lower than the IPO price of ₹44. The IPO ...

Johannesburg - Millions across sub-Saharan Africa face a dire threat as South Africa's National Health Laboratory Service ...